Skip to content
Open access · OA via Europe PMC

A circRNA platform for safe partial reprogramming and rejuvenation of mesenchymal stem cells without pluripotent conversion.

Luo Y, Zhu D, Tian J, Li P, Qin X, Wang J.

Stem cell research & therapy · 2026

Abstract

<h4>Background</h4>Mesenchymal stem cells (MSCs) are widely used in cell therapies; however, replicative senescence(definition) during in vitro expansion limits their potency and consistency. Partial reprogramming(definition) has emerged as a promising strategy to rejuvenate aged cells, yet concerns regarding unintended pluripotent conversion have hindered its translational application.<h4>Methods</h4>Here we developed a circular RNA (circRNA)-based platform enabling safe partial reprogramming and rejuvenation of MSCs. We generated a lipid nanoparticle (LNP)-delivered circRNA co-expressing OCT4, SOX2, and KLF4 (circ-OSK) to achieve transient and coordinated expression of partial reprogramming factors without genomic modification in MSCs. Using a rigorously validated droplet digital PCR (ddPCR) system targeting the pluripotency marker ESRG, we demonstrated that circ-OSK delivery alone is insufficient to transform MSCs into induced pluripotent stem cells (iPSCs).<h4>Results</h4>Circ-OSK-mediated partial reprogramming significantly rejuvenated senescent late-passage MSCs by reducing senescence-associated β-galactosidase activity, DNA damage markers, and inflammatory cytokine secretion, while preserving canonical MSC surface markers and genome stability, and restoring proliferative, migratory and tri-lineage differentiation capacities at a level comparable to early-passage MSCs. The rejuvenated MSCs generated through this process are defined as partially reprogrammed MSCs (prMSCs). Further RNA-seq analysis revealed that prMSCs restored youthful gene expression and promoted a stress resilient and regenerative transcriptional program via repressing the PI3K-Akt signaling pathway. Combined RNA-seq and SNP array analysis confirmed circ-OSK-mediated partial reprogramming retained MSC identity and genome integrity without pluripotent conversion.<h4>Conclusions</h4>Our study has established a circRNA-mediated partial reprogramming strategy that rejuvenates MSCs without pluripotent conversion, offering a safety-oriented approach to enhance the potency and quality of MSC-based cell therapy products.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
DOI
10.1186/s13287-026-05193-0
Canonical
link ↗
Fetched
2026-10-25 MST

Cite this

APA
Y, L., D, Z., J, T., P, L., X, Q., &amp; J., W. (2026). A circRNA platform for safe partial reprogramming and rejuvenation of mesenchymal stem cells without pluripotent conversion. <em>Stem cell research & therapy</em>. https://doi.org/10.1186/s13287-026-05193-0
Vancouver
Y L, D Z, J T, P L, X Q, J. W. A circRNA platform for safe partial reprogramming and rejuvenation of mesenchymal stem cells without pluripotent conversion. Stem cell research & therapy. 2026. doi:10.1186/s13287-026-05193-0.
BibTeX
@article{luo2026AcircR, title = {A circRNA platform for safe partial reprogramming and rejuvenation of mesenchymal stem cells without pluripotent conversion.}, author = {Luo Y and Zhu D and Tian J and Li P and Qin X and Wang J.}, journal = {Stem cell research & therapy}, year = {2026}, doi = {10.1186/s13287-026-05193-0}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings